Why Us?

Dependable Benefits for your Patients, Providers and Stakeholders

Strategic and Commercial Benefits

Our platform has direct and measurable positive implications for clinical capacity, trial recruitment, drug approvals, pharma revenue, enterprise value, and patient outcomes

Improved Clinical Capacity

Increase your clinical capacity by translating healthcare data into repeatable and measurable operational intelligence and clinical decisioning.

Local Partnerships

We partner with hospital and healthcare stakeholders and leverage local domain expertise for clinician led analytics and real world relevant evidence for each critical discipline workflow.

Improve Decision Making Confidence

We provide structured, insightful, realtime data to assure and enhance clinical and logistical decisions at the point of intervention. Our framework supports also operational, resourcing, cost performance decisions and allows for reliable operational evaluation of innovation investments and performance.

Data Security and Sovereignty

Our default deployment strategy uses a SecureEdge AI architecture deployed within the stakeholders sovereign domain. Our architecture has strict controls on the privacy of patient data and data ownership rules.

Collaborative Deployment

Our collaborative deployment model is a refreshing break from traditional healthcare software approaches which have consistently failed to provide security and operational benefits.

Deploy AI platform first and hope it improves workflows

Define workflows first via Forensic Gap Analysis. Match tech to reality


Centralised cloud storage

Distributed bare-metal edge with on-premise sovereignty


Sensitive data in cloud in servers and providers subject to adverse privacy laws

SecureEdge local deployment with local data oversight; Swiss NAIPO compliant


Vendor-client transaction with arbitrary license and subscription fees for data access and non-performing services

Embedded partnership with performance oriented ROCE sharing


Lead by sales teams and consultants with limited clinical validation

Lead by clinical teams in partnership with a 32 member advisory board


Misaligned with needs

Proven ROI